ATE109349T1 - 3-substituierte-2-oxindolderivate als interleukin-biosynthesehemmer. - Google Patents

3-substituierte-2-oxindolderivate als interleukin-biosynthesehemmer.

Info

Publication number
ATE109349T1
ATE109349T1 AT90310806T AT90310806T ATE109349T1 AT E109349 T1 ATE109349 T1 AT E109349T1 AT 90310806 T AT90310806 T AT 90310806T AT 90310806 T AT90310806 T AT 90310806T AT E109349 T1 ATE109349 T1 AT E109349T1
Authority
AT
Austria
Prior art keywords
interleukin
substituted
biosynthesis inhibitors
derivatives
oxindol derivatives
Prior art date
Application number
AT90310806T
Other languages
English (en)
Inventor
Carl Joseph Goddard
Douglas Charles Hanson
Gary Richard Schulte
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE109349T1 publication Critical patent/ATE109349T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90310806T 1989-10-13 1990-10-03 3-substituierte-2-oxindolderivate als interleukin-biosynthesehemmer. ATE109349T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42144589A 1989-10-13 1989-10-13
US52905090A 1990-05-25 1990-05-25

Publications (1)

Publication Number Publication Date
ATE109349T1 true ATE109349T1 (de) 1994-08-15

Family

ID=27025248

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90310806T ATE109349T1 (de) 1989-10-13 1990-10-03 3-substituierte-2-oxindolderivate als interleukin-biosynthesehemmer.

Country Status (14)

Country Link
US (1) US5192790A (de)
EP (1) EP0425109B1 (de)
JP (1) JPH0684300B2 (de)
KR (1) KR910007526A (de)
AT (1) ATE109349T1 (de)
AU (1) AU624739B2 (de)
CA (1) CA2027394C (de)
DE (1) DE69011272T2 (de)
DK (1) DK0425109T3 (de)
HU (2) HUT59004A (de)
IE (1) IE63140B1 (de)
IL (1) IL95880A (de)
MY (1) MY106834A (de)
PT (1) PT95566B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6266485B1 (en) 1998-02-19 2001-07-24 Emerson Electric Co. One-piece plastic tank and temperature control system for a hot water dispenser
JP2002525362A (ja) * 1998-09-30 2002-08-13 エスヴァイン、アンゲリカ 代謝性骨障害の治療および予防のためのロダニンカルボン酸誘導体
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
IN162090B (de) * 1984-03-19 1988-03-26 Pfizer
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
IN161509B (de) * 1984-05-04 1987-12-19 Pfizer
US4678802A (en) * 1985-07-09 1987-07-07 Pfizer Inc. 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents
GB8517958D0 (en) * 1985-07-16 1985-08-21 Cellena Cell Eng Ag Compositions containing melatonin/homologues
AU6898287A (en) * 1986-01-30 1987-08-25 University Of Utah, The Treatment of bone loss
US4677132A (en) * 1986-03-12 1987-06-30 American Home Products Corporation Inhibition of bone resorption by etodolac
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives

Also Published As

Publication number Publication date
HU210902A9 (en) 1995-09-28
EP0425109B1 (de) 1994-08-03
IE903648A1 (en) 1991-04-24
PT95566B (pt) 1997-11-28
AU624739B2 (en) 1992-06-18
CA2027394A1 (en) 1991-04-14
DE69011272D1 (de) 1994-09-08
AU6458290A (en) 1991-04-18
DK0425109T3 (da) 1994-11-21
EP0425109A3 (en) 1992-01-15
HU906436D0 (en) 1991-04-29
MY106834A (en) 1995-07-31
KR910007526A (ko) 1991-05-30
CA2027394C (en) 1995-01-03
JPH03133929A (ja) 1991-06-07
EP0425109A2 (de) 1991-05-02
HUT59004A (en) 1992-04-28
IE63140B1 (en) 1995-03-22
PT95566A (pt) 1991-08-14
US5192790A (en) 1993-03-09
JPH0684300B2 (ja) 1994-10-26
DE69011272T2 (de) 1994-11-24
IL95880A (en) 1995-12-31

Similar Documents

Publication Publication Date Title
DE69435086D1 (de) Phenylacetate und Derivate, allein oder in Kombination mit anderen Verbindungen, zur Behandlung von neoplastischen und anderen Erkrankungen
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
PL398445A1 (pl) Kompozycje farmaceutyczne zawierające dekstrometorfan i chininę do leczenia zaburzeń neurologicznych
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
DE58902712D1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
DK174389A (da) Anvendelse af 3-substituerede 2-oxindol-1-carboxamid-forbindelser til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-biosyntese
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
DE69011272D1 (de) 3-Substituierte-2-Oxindolderivate als Interleukin-Biosynthesehemmer.
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
IT8467682A0 (it) Composizione farmaceutica sinergistica per il trattamento di disturbi epatici contenente 4(5)-amminoimidazolo-5(4)carbossamide ortofosfato e vitamine
ATE208402T1 (de) Pharmazeutische zusammensetzung enthaltend interferon-gamma inhibitoren
DK0608648T3 (da) Højdoserede vitamin A-præparater
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee